D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 42 Citations 7,406 140 World Ranking 3834 National Ranking 5

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Internal medicine
  • Antibody

Sutee Yoksan mainly focuses on Dengue fever, Immunology, Virology, Dengue virus and Dengue vaccine. His studies deal with areas such as Secondary infection, Viremia, Internal medicine, Flavivirus and Seroconversion as well as Dengue fever. His research investigates the connection between Immunology and topics such as Attenuated vaccine that intersect with issues in Headaches and Recombinant virus.

In Virology, he works on issues like Immunogenicity, which are connected to Neutralizing antibody. His Dengue virus research is multidisciplinary, incorporating perspectives in Outbreak response, Antibody, Immunoglobulin M and Immune system. His Vaccination study integrates concerns from other disciplines, such as Adverse effect, Serotype and Reactogenicity.

His most cited work include:

  • Dengue: a continuing global threat (1262 citations)
  • Evaluation of diagnostic tests: dengue. (342 citations)
  • A variant in the CD209 promoter is associated with severity of dengue disease. (264 citations)

What are the main themes of his work throughout his whole career to date?

Sutee Yoksan mainly investigates Virology, Dengue fever, Immunology, Dengue virus and Japanese encephalitis. Sutee Yoksan has included themes like Antibody and Antigen in his Virology study. Sutee Yoksan is involved in the study of Dengue fever that focuses on Dengue vaccine in particular.

Immunology connects with themes related to Adverse effect in his study. His Antibody-dependent enhancement study in the realm of Dengue virus connects with subjects such as Original antigenic sin. In his study, which falls under the umbrella issue of Japanese encephalitis, Seroprevalence is strongly linked to Plaque reduction neutralization test.

He most often published in these fields:

  • Virology (65.38%)
  • Dengue fever (60.26%)
  • Immunology (50.00%)

What were the highlights of his more recent work (between 2013-2021)?

  • Virology (65.38%)
  • Dengue fever (60.26%)
  • Dengue virus (35.90%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Virology, Dengue fever, Dengue virus, Immunology and Japanese encephalitis. Sutee Yoksan focuses mostly in the field of Virology, narrowing it down to topics relating to Antibody and, in certain cases, Antigen. His Dengue fever research is multidisciplinary, incorporating elements of Transmission, Thalassemia, Immune system and Serum samples.

His Dengue virus research is multidisciplinary, relying on both Capture elisa, Serotype, Igm elisa, Flavivirus and In vivo. His Japanese encephalitis study combines topics in areas such as Titer, Plaque reduction neutralization test, Seroprevalence and Zika virus. His Japanese encephalitis vaccine study incorporates themes from Booster dose, Adverse effect, Immunogenicity, Vaccination and Seroconversion.

Between 2013 and 2021, his most popular works were:

  • Dengue Virus Infection Induces Expansion of a CD14+CD16+ Monocyte Population that Stimulates Plasmablast Differentiation (141 citations)
  • Evaluation of commercially available diagnostic tests for the detection of dengue virus NS1 antigen and anti-dengue virus IgM antibody. (94 citations)
  • Human T cell responses to Japanese encephalitis virus in health and disease (54 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Internal medicine
  • Antibody

His primary areas of investigation include Virology, Dengue virus, Immunology, Dengue fever and Virus. His study in Virology is interdisciplinary in nature, drawing from both Antibody and Antigen. His biological study focuses on Dengue vaccine.

His Dengue fever research includes elements of CD14, Immune system and Monocyte. The study incorporates disciplines such as Lipogenesis, Fatty acid synthase, Gene expression and Microbiology in addition to Virus. His Japanese encephalitis research focuses on Zika virus and how it relates to Flavivirus, Serum samples and Transmission.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Dengue: a continuing global threat

Maria G. Guzman;Scott B. Halstead;Harvey Artsob;Philippe Buchy.
Nature Reviews Microbiology (2010)

2277 Citations

Evaluation of diagnostic tests: dengue.

Rosanna W. Peeling;Rosanna W. Peeling;Harvey Artsob;Jose Luis Pelegrino;Philippe Buchy.
Nature Reviews Microbiology (2010)

598 Citations

A variant in the CD209 promoter is associated with severity of dengue disease.

Anavaj Sakuntabhai;Anavaj Sakuntabhai;Chairat Turbpaiboon;Chairat Turbpaiboon;Isabelle Casadémont;Ampaiwan Chuansumrit.
Nature Genetics (2005)

384 Citations

Diagnostic accuracy of NS1 ELISA and lateral flow rapid tests for dengue sensitivity, specificity and relationship to viraemia and antibody responses.

Vu Thi Ty Hang;Nguyen Minh Nguyet;Vianney Tricou.
PLOS Neglected Tropical Diseases (2009)

292 Citations

Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.

Thomas P. Monath;Farshad Guirakhoo;Richard Nichols;Sutee Yoksan.
The Journal of Infectious Diseases (2003)

287 Citations

Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses.

Arunee Sabchareon;Jean Lang;Pornthep Chanthavanich;Sutee Yoksan.
American Journal of Tropical Medicine and Hygiene (2002)

279 Citations

Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

Thomas P Monath;Karen McCarthy;Philip Bedford;Casey T Johnson.
Vaccine (2002)

272 Citations

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

Farshad Guirakhoo;Scott Kitchener;Dennis Morrison;Remi Forrat.
Human Vaccines (2006)

266 Citations

Evaluation of commercially available anti-dengue virus immunoglobulin M tests.

Elizabeth A Hunsperger;Sutee Yoksan;Philippe Buchy;van Vinh Chau Nguyen.
Emerging Infectious Diseases (2009)

266 Citations

Rapid and massive virus specific plasmablast responses during acute dengue virus infection in humans

Jens Wrammert;Nattawat Onlamoon;Rama Akondy;Guey Chuen 'Oscar' Perng.
Journal of Virology (2012)

232 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Sutee Yoksan

Eva Harris

Eva Harris

University of California, Berkeley

Publications: 62

Cameron P. Simmons

Cameron P. Simmons

University College London

Publications: 52

Stephen S. Whitehead

Stephen S. Whitehead

National Institute of Allergy and Infectious Diseases

Publications: 51

Annelies Wilder-Smith

Annelies Wilder-Smith

University of Bern

Publications: 51

Yee Sin Leo

Yee Sin Leo

Nanyang Technological University

Publications: 42

Scott B. Halstead

Scott B. Halstead

Uniformed Services University of the Health Sciences

Publications: 41

Anna P. Durbin

Anna P. Durbin

Johns Hopkins University

Publications: 38

María G. Guzmán

María G. Guzmán

Instituto de Medicina Tropical “Pedro Kourí”

Publications: 36

Jean Lang

Jean Lang

Sanofi (France)

Publications: 36

Alan L. Rothman

Alan L. Rothman

University of Rhode Island

Publications: 35

Thomas P. Monath

Thomas P. Monath

Crozet BioPharma

Publications: 35

Prida Malasit

Prida Malasit

National Science and Technology Development Agency

Publications: 34

Eng Eong Ooi

Eng Eong Ooi

National University of Singapore

Publications: 33

Anavaj Sakuntabhai

Anavaj Sakuntabhai

Institut Pasteur

Publications: 32

Ernesto T. A. Marques

Ernesto T. A. Marques

University of Pittsburgh

Publications: 31

Duncan R. Smith

Duncan R. Smith

Mahidol University

Publications: 31

Trending Scientists

Ben Kaczer

Ben Kaczer

Imec

Afzal S. Siddiqui

Afzal S. Siddiqui

University College London

Richard A. Durst

Richard A. Durst

Cornell University

Lizbeth Hedstrom

Lizbeth Hedstrom

Brandeis University

Jacqueline F. Sinclair

Jacqueline F. Sinclair

Dartmouth College

Deborah M. Power

Deborah M. Power

University of Algarve

Marc Van Ranst

Marc Van Ranst

KU Leuven

Göran Molin

Göran Molin

Lund University

Larry Mahrt

Larry Mahrt

Northwest Research Associates

Matthew J. Cohen

Matthew J. Cohen

University of Florida

Paul J. Lioy

Paul J. Lioy

Rutgers, The State University of New Jersey

Leendert A. Trouw

Leendert A. Trouw

Leiden University Medical Center

Kenneth A. Egol

Kenneth A. Egol

New York University

Robert H. Bartlett

Robert H. Bartlett

University of Michigan–Ann Arbor

John H. Suh

John H. Suh

Cleveland Clinic

Heather Joshi

Heather Joshi

University College London

Something went wrong. Please try again later.